Print

Synageva BioPharma (GEVA) to Present at the Cowen and Company 33rd Annual Health Care Conference  
2/26/2013 9:27:56 AM

Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today announced its presentation at the upcoming Cowen and Company 33rd Annual Health Care Conference.
//-->